BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Biotech Beach

  13-Employee SoCal Startup Bioniz Has A $400 Million Valuation

  Forbes recently interviewed Nazli Azimi, the CEO and co-founder of Bioniz Therapeutics.

  December 20, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Policy

  Bay Area Align Tech Terminates Interoperability Pact With 3Shape

  Last month Align Tech filed formal patent infringement complaints against medical device maker 3Shape.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• Business

  Visioneering Technologies Welcomes Senior Life Sciences Executive Jean Franchi to its Board of Directors

  VTI is pleased to announce the appointment of Ms. Jean Franchi to its Board of Directors, and as Chair of the Audit and Risk Committee.

  December 20, 2017

   · 

  1 min read
• 

  Policy

  Zimmer Biomet Loses Bid to Cut $16M Plaintiff Award in Knee Suit

  The lawsuit filed by Margo Polett claimed that she re-injured her knees while making a Zimmer promotional video, after a double knee replacement procedure in 2006 using the company’s Gender Solutions device.

  December 20, 2017

   · 

  1 min read
• 

  Drug Development

  AbbVie Scores Key Trial Win for RA Drug With One Fatal Event Reported

  AbbVie’s investigational JAK1-inhibitor upadacitinib yielded positive top-line results in a Phase III trial as a monotherapy for rheumatoid arthritis patients.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  BioCapital

  Why This Little Known Biotech Is Pharma’s New Poster Child for Price Gouging

  Another lawmaker is taking on a pharmaceutical company for drug pricing.

  December 20, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  Takeover Whispers Boost Shire, Mega Deal to Bring Shareholders an Early Christmas Present

  Takeover whispers boosted long-standing target Shire to the top of the FTSE 100 as the pharma firm’s shares rallied on hopes of a mega deal bringing shareholders an early Christmas present.

  December 20, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Bio NC

  Top 6 Biotech Stocks of 2017

  When considering options in the biotech sector, experts often look more into the major companies providing massive amounts of resources to new candidates.

  December 20, 2017

   · 

  1 min read
• 

  Business

  Indiana’s Richest Person is Medical Device Billionaire Carl Cook

  For over 50 years, Cook Group’s catheters, filters and stents have helped patients get healthy, and proceeds from their sales make up the bulk of heir and CEO Carl Cook’s fortune.

  December 20, 2017

   · 

  1 min read
• 

  Biotech Bay

  7 Hot Biotech Investing Bets

  We now turn to six MoneyShow.com contributors for their best ideas in biotechnology, a sector with both high risk and the potential for high rewards.

  December 20, 2017

   · 

  1 min read